Γ

SynBioBeta Speaker

Esteban Toro

Twist Bioscience

CSO, Biopharma

Dr. Esteban Toro serves as the Vice President of Research and Development at Twist Bioscience, a leading synthetic biology company based in South San Francisco, California. In this role, he oversees the development of technologies and products at the intersection of molecular biology and computation, focusing on genomics and synthetic biology applications.With a Ph.D. from Stanford University, Dr. Toro has led both wet lab and dry lab teams, building integrated products that span the central dogma of molecular biology—DNA, RNA, and proteins. His work emphasizes the integration of computational tools with molecular biology to accelerate research and development processes. His teams focus on protein engineering, DNA and RNA manufacturing, sample preparation for NGS sequencing, hybrid capture, synthetic control materials, and high throughput antibody production and characterization. Beyond his role at Twist Bioscience, Dr. Toro is affiliated with the Synthetic biology Manufacturing of Advanced materials Research Center (SMARC) at Washington University in St. Louis, reflecting his commitment to advancing the field of synthetic biology through both industry and academic collaborations. He also co-founded and serves on the board of Aterio, Inc. a data modeling and insights company.

Sessions Featuring

Esteban

This Year

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include